Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda Winters, Daniel A. Pollyea, Jeff Kaiser et al.|Blood Advances|2019Cited by 147
Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantationPrashant Sharma, Jonathan A. Gutman, Neel Gakhar et al.|Bone Marrow Transplantation|2019Cited by 39
Tumor lysis syndrome (TLS) in acute myeloid leukemia (AML) patients treated with azacitidine (AZA) and venetoclax (VEN).Joanna Q. Huang, Jeff Kaiser, Emmeline C. Academia et al.|Journal of Clinical Oncology|2020Cited by 5